Immunohistochemical analysis of the expression of MAGE-A and NY-ESO-1 cancer/testis antigens in diffuse large B-cell testicular lymphoma
Open Access
- 16 May 2013
- journal article
- research article
- Published by Springer Science and Business Media LLC in Journal of Translational Medicine
- Vol. 11 (1), 123-6
- https://doi.org/10.1186/1479-5876-11-123
Abstract
Primary testicular lymphoma (PTL) is a rare and lethal disease. The most common histological subtype is diffuse large B-cell lymphoma (DLBCL). Standard treatments are frequently ineffective. Thus, the development of novel forms of therapy is urgently required. Specific immunotherapy generating immune responses directed against antigen predominantly expressed by cancer cells such as cancer-testis antigens (CTA) may provide a valid alternative treatment for patients bearing PTL, alone or in combination with current therapies. Three monoclonal antibodies (mAbs), 77B recognizing MAGE-A1, 57B recognizing an epitope shared by multiple MAGE-A CTA (multi-MAGE-A specific) and D8.38 recognizing NY-ESO-1/LAGE-1 were used for immunohistochemical staining of 27 PTL, including 24 DLBCL. Expression of MAGE-A1 was infrequently detectable in DLBCL specimens (12.50%), whereas multi-MAGE-A and NY-ESO-1/LAGE-1 specific reagents stained the cytoplasms of tumor cells in DLBCL specimens with higher frequencies (54.17% and 37.50%, respectively) with different expression levels. These results suggest that MAGE-A and NY-ESO-1/LAGE-1, possibly in combination with other CTA, might be used as targets for specific immunotherapy in DLBCL.Keywords
This publication has 25 references indexed in Scilit:
- Detection of circulating lymphoma cells in patients with non-Hodgkin lymphoma using MAGE-A3 gene expression in peripheral bloodLeukemia Research, 2010
- Cancer/testis antigens, gametogenesis and cancerNature Reviews Cancer, 2005
- NY‐ESO‐1/LAGE‐1 coexpression with MAGE‐A cancer/testis antigens: A tissue microarray studyInternational Journal of Cancer, 2005
- Testicular lymphoma A Retrospective, Population-based, Clinical and Immunohistochemical StudyActa Oncologica, 2004
- Testicular Lymphoma: Organ-Specific Treatment Did Not Improve OutcomeOncology, 2004
- Cancer/testis‐associated genes: Identification, expression profile, and putative functionJournal of Cellular Physiology, 2003
- Expression of cancer/testis antigens in cutaneous T cell lymphomasInternational Journal of Cancer, 2001
- Cancer Tumor antigensCurrent Opinion in Immunology, 1997
- MAGE‐1 gene product is a cytoplasmic proteinInternational Journal of Cancer, 1994
- Malignant Lymphoma of the Testis, Epididymis, and Spermatic CordThe American Journal of Surgical Pathology, 1994